Epidemiology of healthcare-associated infections and mechanisms of antimicrobial resistance of responsible pathogens in Ukraine: a multicentre study

Salmanov, Aidyn G; Shchehlov, D.V.; Svyrydiuk, O.E.; Bortnik, Ihor M.; Mamonova, M.Yu.; Korniyenko, S. M.; Rud, Victor; Artyomenko, Volodymyr; Gudym, M.S.; Maliarchuk, Rostyslav; Bondar, Taras

doi:10.1016/j.jhin.2022.10.007

Cited by 22 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is probably attributable to the medical evacuation of patients from Ukrainian hospitals. OXA-type and NDM-1 have been reported as the most frequent alleles among carbapenemase-positive MDRO causing hospital-acquired infections in Ukraine, but carbapenemase allele combinations were not reported [ 8 ]. Limitations of our study are the lack of denominator data, including how the number of MDRO from patients from Ukraine relates to the total number of patients, the monthly number of hospitalisations in the Netherlands, and how many patients from Ukraine have been screened for MDRO or how many were not colonised with an MDRO.…”

Section: Discussionmentioning

confidence: 99%

“…The European Centre for Disease Prevention and Control (ECDC) advised to pre-emptively isolate patients transferred from hospitals in Ukraine or with a history of hospital admission in Ukraine in the last 12 months and to screen for carriage of MDRO [ 6 ]. Available information from Ukrainian military and general hospitals indicates high prevalence of MDRO in Ukraine between 2014 and 2021 [ 3 , 7 , 8 ]. Percentages of resistance of 17–84% against third-generation cephalosporins and carbapenems among Enterobacterales and P. aeruginosa , and > 50% resistance to carbapenems, fluoroquinolones and aminoglycosides among Acinetobacter species have been reported [ 3 , 7 , 8 ].…”

Section: Multidrug-resistant Organisms In the Netherlands And Ukrainementioning

confidence: 99%

“…Available information from Ukrainian military and general hospitals indicates high prevalence of MDRO in Ukraine between 2014 and 2021 [ 3 , 7 , 8 ]. Percentages of resistance of 17–84% against third-generation cephalosporins and carbapenems among Enterobacterales and P. aeruginosa , and > 50% resistance to carbapenems, fluoroquinolones and aminoglycosides among Acinetobacter species have been reported [ 3 , 7 , 8 ]. European surveillance data for Ukraine indicated 18% of S. aureus to be meticillin-resistant, while 41% meticillin-resistance was reported in healthcare-associated S. aureus infections [ 3 , 8 ].…”

Section: Multidrug-resistant Organisms In the Netherlands And Ukrainementioning

confidence: 99%

“…Percentages of resistance of 17–84% against third-generation cephalosporins and carbapenems among Enterobacterales and P. aeruginosa , and > 50% resistance to carbapenems, fluoroquinolones and aminoglycosides among Acinetobacter species have been reported [ 3 , 7 , 8 ]. European surveillance data for Ukraine indicated 18% of S. aureus to be meticillin-resistant, while 41% meticillin-resistance was reported in healthcare-associated S. aureus infections [ 3 , 8 ]. However, these percentages are based on isolates from hospitalised patients and may therefore not be representative for MDRO carriage in the community [ 3 , 7 ].…”

Section: Multidrug-resistant Organisms In the Netherlands And Ukrainementioning

confidence: 99%

See 3 more Smart Citations

Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

et al. 2022

View full text Add to dashboard Cite

Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority of the MDRO represent globally spread epidemic lineages and that 60% contain New Delhi metallo-β-lactamase (NDM) genes. Professionals should be aware of an increase in such MDRO associated with migration and medical evacuation of people from Ukraine.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Multidrug-resistant Organisms In the Netherlands And Ukrainementioning

confidence: 99%

Section: Multidrug-resistant Organisms In the Netherlands And Ukrainementioning

confidence: 99%

Section: Multidrug-resistant Organisms In the Netherlands And Ukrainementioning

confidence: 99%

See 2 more Smart Citations

Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

et al. 2022

View full text Add to dashboard Cite

show abstract

Moving toward point-of-care surgery in Ukraine: testing an ultra-portable operating room in an active war zone

Lagazzi,

Teodorescu,

Argandykov

et al. 2024

Eur J Trauma Emerg Surg

View full text Add to dashboard Cite

The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008–2018: expanding surveillance using existing laboratory and register data

Danielsen,

Elstrøm,

Eriksen-Volle

et al. 2023

Eur J Clin Microbiol Infect Dis

View full text Add to dashboard Cite

Surveillance has revealed an increase of multidrug-resistant organisms (MDROs), even in low-prevalent settings such as Norway. MDROs pose a particular threat to at-risk populations, including persons with cancer. It is necessary to include such populations in future infection surveillance. By combining existing data sources, we aimed to describe the epidemiology of MDROs in persons diagnosed with cancer in Norway from 2008 to 2018. A cohort was established using data from the Cancer Registry of Norway, which was then linked to notifications of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin- and/or linezolid-resistant enterococci (V/LRE), and carbapenemase-producing Gram-negative bacilli (CP-GNB) from the Norwegian Surveillance System for Communicable Diseases, and laboratory data on third-generation cephalosporin-resistant Enterobacterales (3GCR-E) from Oslo University Hospital (OUH). We described the incidence of MDROs and resistance proportion in Enterobacterales from 6 months prior to the person’s first cancer diagnosis and up to 3 years after. The cohort included 322,005 persons, of which 0.3% (878) were diagnosed with notifiable MDROs. Peak incidence rates per 100,000 person-years were 60.9 for MRSA, 97.2 for V/LRE, and 6.8 for CP-GNB. The proportion of 3GCR-E in Enterobacterales in blood or urine cultures at OUH was 6% (746/12,534). Despite overall low MDRO incidence, there was an unfavourable trend in the incidence and resistance proportion of Gram-negative bacteria. To address this, there is a need for effective infection control and surveillance. Our study demonstrated the feasibility of expanding the surveillance of MDROs and at-risk populations through the linkage of existing laboratory and register data.

show abstract

Epidemiology of healthcare-associated infections and mechanisms of antimicrobial resistance of responsible pathogens in Ukraine: a multicentre study

Cited by 22 publications

References 22 publications

Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

Moving toward point-of-care surgery in Ukraine: testing an ultra-portable operating room in an active war zone

The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008–2018: expanding surveillance using existing laboratory and register data

Contact Info

Product

Resources

About